Dendritic cell vaccination and immune monitoring (original) (raw)
Dendritic Cells in Cancer Immunotherapy
Edgar Engleman
Annual Review of Immunology, 2000
View PDFchevron_right
Exploiting dendritic cells in the development of cancer vaccines
Enrico Proietti
Expert Review of Vaccines, 2013
View PDFchevron_right
Dendritic cell preparation for immunotherapeutic interventions
Marc Grégoire
2009
View PDFchevron_right
Dendritic cells in cancer immunology and immunotherapy
Marta Santisteban
Nature Reviews Immunology, 2019
View PDFchevron_right
Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors
Massimo Framarini
Frontiers in Immunology
View PDFchevron_right
Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients
I Jolanda Vries, Nicole Scharenborg
Clinical Cancer Research
View PDFchevron_right
Guiding the “misguided” - functional conditioning of dendritic cells for the DC-based immunotherapy against tumours
Christina To
European Journal of Immunology, 2011
View PDFchevron_right
Dendritic Cells Capture Killed Tumor Cells and Present Their Antigens to Elicit Tumor-Specific Immune Responses
Jean Davoust
The Journal of Immunology, 2000
View PDFchevron_right
Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients
Annemiek Boer
Clinical Cancer Research, 2011
View PDFchevron_right
Dendritic cells in cancer vaccines
Peter Brossart
Experimental Hematology, 2001
View PDFchevron_right
Dendritic cells and tumor immunity
Georg Varga
Seminars in Immunology, 2001
View PDFchevron_right
Eggert AA, Schreurs MW, Boerman OC, Oyen WJ, de Boer AJ, Punt CJ, Figdor CG, Adema GJBiodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res 59: 3340-3345
Annemiek Boer
Cancer Research
View PDFchevron_right
Dendritic cell vaccines in melanoma: From promise to proof?
Danita Schuurhuis, I Jolanda Vries, Gosse Adema, Erik Aarntzen
Critical Reviews in Oncology/Hematology, 2008
View PDFchevron_right
Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results
Gosse Adema
Annals of Oncology, 2004
View PDFchevron_right
Dendritic Cell-Based Vaccines in Cancer
H. kim Lyerly
American Journal of Cancer, 2002
View PDFchevron_right
Dendritic Cells in Antitumor Immune Responses
Jay Berzofsky
Cellular Immunology, 1996
View PDFchevron_right
Enhanced Antitumor Immunity Elicited by Dendritic Cell Vaccines Is a Result of Their Ability to Engage Both CTL and IFNγ-Producing NK Cells
Jeanette Boudreau
Molecular …, 2007
View PDFchevron_right
Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies
yunfeng ma
Frontiers in Immunology
View PDFchevron_right
A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection
A. Tuettenberg, Helmut Jonuleit
International Journal of Cancer, 2001
View PDFchevron_right
Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
Annemiek Boer
OncoImmunology, 2016
View PDFchevron_right
Mediators of Innate Immunity That Target Immature, But Not Mature, Dendritic Cells Induce Antitumor Immunity When Genetically Fused with Nonimmunogenic Tumor Antigens
DE YANG
View PDFchevron_right
Unpulsed dendritic cells induce broadly applicable anti-tumor immunity in mice
Albert DeLeo
Cancer Biology & Therapy, 2005
View PDFchevron_right
Prolonged Survival of Dendritic Cell-Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor -Expressing T Cells
Diego Reyes, M. Larrondo, Francisco Moya
Journal of Clinical Oncology, 2009
View PDFchevron_right
Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells
Diego Reyes
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009
View PDFchevron_right
Dendritic cells and cancer immunotherapy
Mireille Lahoud
Current Opinion in Immunology, 2014
View PDFchevron_right
Induction of cytotoxic T lymphocytes primed with Tumor RNA-loaded Dendritic Cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design
Reza Malekzadeh
BMC Cancer, 2010
View PDFchevron_right
Schreurs, MW, Eggert, AA, de Boer, AJ, Vissers, JL, van Hall, T, Offringa, R et al.. Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model. Cancer Res 60: 6995-7001
Annemiek Boer
Cancer Research
View PDFchevron_right
Clinical implications of antigen transfer mechanisms from malignant to dendritic cells
Carlos Alfaro
Experimental Hematology, 2002
View PDFchevron_right
Targeting dendritic cells for priming cellular immune responses
Éva Rajnavölgyi, Peter Gogolak
Journal of Molecular Recognition, 2003
View PDFchevron_right
Tumoricidal activity of human dendritic cells
Evelien Smits
Trends in Immunology, 2014
View PDFchevron_right